You are here: Industry Insights > COVID-19

News List

Memo Therapeutics Collaborates with Northway Biotechpharma contractpharma
August 18, 2020
Will fast-track cGMP manufacturing of a SARS-CoV-2 neutralizing antibody.
UK Govt. Buys 60 Million Doses of Novavax’ COVID-19 Vax Candidate contractpharma
August 18, 2020
Fujifilm Diosynth Biotechnologies to manufacture antigen component of NVX-CoV2373 in the UK.
Race to find a viable vaccine: Can Indian firms rise to the challenge? expresspharma
August 18, 2020
Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca gives an overview of India’s capabilities to develop and manufacture vaccines.
Fusion Health Care launches favipiravir for COVID-19 treatment expresspharma
August 18, 2020
Fusion Health Care, a pharma company based at Hyderabad, has announced the launch of its favipiravir drug under the brand name XARAVIR, for the treatment of mild to moderate COVID-19 cases.
Online pharmacies urge government to notify e-Pharmacy Draft Rules expresspharma
August 18, 2020
The Indian e-pharmacy market has recorded approximately $700 million investments in during FY20.
WuXi Biologics Records Excellent Interim Results WuXi Biologics
August 18, 2020
WuXi Biologics is pleased to announce its unaudited interim results for the six months ended June 30, 2020.
Romark Initiates Trial of NT-300 for COVID-19 americanpharmaceuticalreview
August 17, 2020
Romark announced the initiation of a Phase 3 clinical trial of its investigational new drug candidate NT-300 (nitazoxanide extended-release tablets) as a treatment for mild or moderate COVID-19.
Phase III trial to study NT-300 as COVID-19 treatment initiated europeanpharmaceuticalreview
August 17, 2020
A Phase III trial to investigate NT-300 (nitazoxanide extended-release tablets) as a treatment for mild or moderate COVID-19 has begun.
Virus uses ‘decoy’ strategy to evade immune system: Otago researchers expresspharma
August 17, 2020
The research demonstrates another manner in which viruses are capable of hijacking infected cells and alerts scientists to the novel mechanism of viral transmission, say scientists.
Atrimed Pharma claims breakthrough in molecule research for COVID-19 cure expresspharma
August 17, 2020
Reportedly, three of its samples tested positive against SARS-CoV-2 in an ICMR-designated laboratory.